Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

HLN vs CL vs PG vs CHD

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HLN
Haleon plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • GB
Market Cap$41.45B
5Y Perf.+32.4%
CL
Colgate-Palmolive Company

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$70.09B
5Y Perf.+10.9%
PG
The Procter & Gamble Company

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$341.30B
5Y Perf.+5.1%
CHD
Church & Dwight Co., Inc.

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$22.24B
5Y Perf.+6.7%

HLN vs CL vs PG vs CHD — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HLN logoHLN
CL logoCL
PG logoPG
CHD logoCHD
IndustryDrug Manufacturers - Specialty & GenericHousehold & Personal ProductsHousehold & Personal ProductsHousehold & Personal Products
Market Cap$41.45B$70.09B$341.30B$22.24B
Revenue (TTM)$22.01B$20.38B$86.72B$6.21B
Net Income (TTM)$3.18B$2.13B$12.72B$733M
Gross Margin63.9%60.1%50.3%45.1%
Operating Margin21.4%21.3%23.2%17.3%
Forward P/E22.2x22.9x21.1x25.0x
Total Debt$8.59B$7.99B$35.46B$2.21B
Cash & Equiv.$1.32B$1.29B$9.56B$409M

HLN vs CL vs PG vs CHDLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HLN
CL
PG
CHD
StockJul 22May 26Return
Haleon plc (HLN)100132.4+32.4%
Colgate-Palmolive C… (CL)100110.9+10.9%
The Procter & Gambl… (PG)100105.1+5.1%
Church & Dwight Co.… (CHD)100106.7+6.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: HLN vs CL vs PG vs CHD

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HLN and PG are tied at the top with 2 categories each — the right choice depends on your priorities. The Procter & Gamble Company is the stronger pick specifically for profitability and margin quality and dividend income and shareholder returns. CHD and CL also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
HLN
Haleon plc
The Defensive Pick

HLN has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and valuation efficiency.

  • Lower volatility, beta 0.06, Low D/E 52.2%, current ratio 0.92x
  • PEG 2.63 vs PG's 3.78
  • Beta 0.06, yield 1.9%, current ratio 0.92x
  • Lower P/E (22.2x vs 25.0x)
Best for: sleep-well-at-night and valuation efficiency
CL
Colgate-Palmolive Company
The Niche Pick

CL is the clearest fit if your priority is efficiency.

  • 12.5% ROA vs CHD's 8.2%, ROIC 43.4% vs 13.9%
Best for: efficiency
PG
The Procter & Gamble Company
The Income Pick

PG is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.

  • Dividend streak 36 yrs, beta 0.10, yield 2.8%
  • 119.3% 10Y total return vs HLN's 31.7%
  • 14.7% margin vs CL's 10.5%
  • 2.8% yield, 36-year raise streak, vs HLN's 1.9%
Best for: income & stability and long-term compounding
CHD
Church & Dwight Co., Inc.
The Growth Play

CHD is the clearest fit if your priority is growth exposure.

  • Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
  • 1.6% revenue growth vs HLN's -4.0%
  • +3.4% vs HLN's -11.7%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCHD logoCHD1.6% revenue growth vs HLN's -4.0%
ValueHLN logoHLNLower P/E (22.2x vs 25.0x)
Quality / MarginsPG logoPG14.7% margin vs CL's 10.5%
Stability / SafetyHLN logoHLNBeta 0.06 vs CHD's 0.14, lower leverage
DividendsPG logoPG2.8% yield, 36-year raise streak, vs HLN's 1.9%
Momentum (1Y)CHD logoCHD+3.4% vs HLN's -11.7%
Efficiency (ROA)CL logoCL12.5% ROA vs CHD's 8.2%, ROIC 43.4% vs 13.9%

HLN vs CL vs PG vs CHD — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HLNHaleon plc
FY 2022
Respiratory Health
100.0%$1.6B
CLColgate-Palmolive Company
FY 2025
Oral, Personal and Home Care
77.4%$15.8B
Pet Nutrition
22.6%$4.6B
PGThe Procter & Gamble Company
FY 2025
Fabric Care And Home Care Segment Member
35.5%$29.6B
Baby, Feminine and Family Care Segment Member
24.3%$20.2B
Beauty Segment
17.9%$15.0B
Health Care Segment Member
14.4%$12.0B
Grooming Segment Member
8.0%$6.7B
CHDChurch & Dwight Co., Inc.
FY 2025
Specialty Products Division
100.0%$299M

HLN vs CL vs PG vs CHD — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPGLAGGINGCHD

Income & Cash Flow (Last 12 Months)

PG leads this category, winning 3 of 6 comparable metrics.

PG is the larger business by revenue, generating $86.7B annually — 14.0x CHD's $6.2B. Profitability is closely matched — net margins range from 14.7% (PG) to 10.5% (CL). On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHLN logoHLNHaleon plcCL logoCLColgate-Palmolive…PG logoPGThe Procter & Gam…CHD logoCHDChurch & Dwight C…
RevenueTrailing 12 months$22.0B$20.4B$86.7B$6.2B
EBITDAEarnings before interest/tax$5.3B$3.9B$21.9B$1.3B
Net IncomeAfter-tax profit$3.2B$2.1B$12.7B$733M
Free Cash FlowCash after capex$3.1B$3.6B$15.0B$1.1B
Gross MarginGross profit ÷ Revenue+63.9%+60.1%+50.3%+45.1%
Operating MarginEBIT ÷ Revenue+21.4%+21.3%+23.2%+17.3%
Net MarginNet income ÷ Revenue+14.5%+10.5%+14.7%+11.8%
FCF MarginFCF ÷ Revenue+14.2%+17.8%+17.3%+17.2%
Rev. Growth (YoY)Latest quarter vs prior year-0.4%+5.8%+7.4%+0.1%
EPS Growth (YoY)Latest quarter vs prior year+18.8%-105.1%+5.8%+2.2%
PG leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

HLN leads this category, winning 6 of 7 comparable metrics.

At 19.0x trailing earnings, HLN trades at a 43% valuation discount to CL's 33.2x P/E. Adjusting for growth (PEG ratio), HLN offers better value at 2.25x vs PG's 4.01x — a lower PEG means you pay less per unit of expected earnings growth.

MetricHLN logoHLNHaleon plcCL logoCLColgate-Palmolive…PG logoPGThe Procter & Gam…CHD logoCHDChurch & Dwight C…
Market CapShares × price$41.4B$70.1B$341.3B$22.2B
Enterprise ValueMkt cap + debt − cash$51.3B$76.8B$367.2B$24.0B
Trailing P/EPrice ÷ TTM EPS19.01x33.22x22.44x31.09x
Forward P/EPrice ÷ next-FY EPS est.22.22x22.88x21.14x25.01x
PEG RatioP/E ÷ EPS growth rate2.25x4.01x
EV / EBITDAEnterprise value multiple13.62x15.43x15.76x18.14x
Price / SalesMarket cap ÷ Revenue2.83x3.44x4.05x3.59x
Price / BookPrice ÷ Book value/share1.87x194.13x6.86x5.73x
Price / FCFMarket cap ÷ FCF15.47x19.29x24.30x20.35x
HLN leads this category, winning 6 of 7 comparable metrics.

Profitability & Efficiency

CL leads this category, winning 4 of 9 comparable metrics.

CL delivers a 2.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $17 for CHD. HLN carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to CL's 21.88x. On the Piotroski fundamental quality scale (0–9), HLN scores 8/9 vs PG's 5/9, reflecting strong financial health.

MetricHLN logoHLNHaleon plcCL logoCLColgate-Palmolive…PG logoPGThe Procter & Gam…CHD logoCHDChurch & Dwight C…
ROE (TTM)Return on equity+19.9%+2.5%+23.8%+17.4%
ROA (TTM)Return on assets+10.0%+12.5%+10.0%+8.2%
ROICReturn on invested capital+7.6%+43.4%+20.1%+13.9%
ROCEReturn on capital employed+8.6%+41.6%+23.0%+14.4%
Piotroski ScoreFundamental quality 0–98657
Debt / EquityFinancial leverage0.52x21.88x0.68x0.55x
Net DebtTotal debt minus cash$7.3B$6.7B$25.9B$1.8B
Cash & Equiv.Liquid assets$1.3B$1.3B$9.6B$409M
Total DebtShort + long-term debt$8.6B$8.0B$35.5B$2.2B
Interest CoverageEBIT ÷ Interest expense7.80x12.37x487.21x15.59x
CL leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — CL and CHD each lead in 2 of 6 comparable metrics.

A $10,000 investment in HLN five years ago would be worth $13,169 today (with dividends reinvested), compared to $11,370 for CHD. Over the past 12 months, CHD leads with a +3.4% total return vs HLN's -11.7%. The 3-year compound annual growth rate (CAGR) favors CL at 5.0% vs CHD's 0.2% — a key indicator of consistent wealth creation.

MetricHLN logoHLNHaleon plcCL logoCLColgate-Palmolive…PG logoPGThe Procter & Gam…CHD logoCHDChurch & Dwight C…
YTD ReturnYear-to-date-5.6%+13.8%+4.5%+14.0%
1-Year ReturnPast 12 months-11.7%-1.6%-5.6%+3.4%
3-Year ReturnCumulative with dividends+10.4%+15.7%+1.9%+0.7%
5-Year ReturnCumulative with dividends+31.7%+18.2%+22.4%+13.7%
10-Year ReturnCumulative with dividends+31.7%+47.0%+119.3%+113.6%
CAGR (3Y)Annualised 3-year return+3.4%+5.0%+0.6%+0.2%
Evenly matched — CL and CHD each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CL and CHD each lead in 1 of 2 comparable metrics.

CL is the less volatile stock with a -0.00 beta — it tends to amplify market swings less than CHD's 0.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.5% from its 52-week high vs HLN's 81.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHLN logoHLNHaleon plcCL logoCLColgate-Palmolive…PG logoPGThe Procter & Gam…CHD logoCHDChurch & Dwight C…
Beta (5Y)Sensitivity to S&P 5000.06x-0.00x0.10x0.14x
52-Week HighHighest price in past year$11.42$99.33$170.99$106.04
52-Week LowLowest price in past year$8.71$74.55$137.62$81.33
% of 52W HighCurrent price vs 52-week peak+81.5%+87.9%+85.4%+88.5%
RSI (14)Momentum oscillator 0–10036.058.153.749.1
Avg Volume (50D)Average daily shares traded8.0M5.6M7.2M1.8M
Evenly matched — CL and CHD each lead in 1 of 2 comparable metrics.

Analyst Outlook

PG leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: HLN as "Buy", CL as "Hold", PG as "Buy", CHD as "Buy". Consensus price targets imply 10.8% upside for PG (target: $162) vs 6.1% for CHD (target: $100). For income investors, PG offers the higher dividend yield at 2.75% vs CHD's 1.25%.

MetricHLN logoHLNHaleon plcCL logoCLColgate-Palmolive…PG logoPGThe Procter & Gam…CHD logoCHDChurch & Dwight C…
Analyst RatingConsensus buy/hold/sellBuyHoldBuyBuy
Price TargetConsensus 12-month target$10.20$93.70$161.88$99.60
# AnalystsCovering analysts4455234
Dividend YieldAnnual dividend ÷ price+1.9%+2.6%+2.8%+1.3%
Dividend StreakConsecutive years of raises253623
Dividend / ShareAnnual DPS$0.13$2.25$4.02$1.18
Buyback YieldShare repurchases ÷ mkt cap+2.1%+1.7%+1.9%+4.0%
PG leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

PG leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). HLN leads in 1 (Valuation Metrics). 2 tied.

Best OverallThe Procter & Gamble Company (PG)Leads 2 of 6 categories
Loading custom metrics...

HLN vs CL vs PG vs CHD: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is HLN or CL or PG or CHD a better buy right now?

For growth investors, Church & Dwight Co.

, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -4. 0% for Haleon plc (HLN). Haleon plc (HLN) offers the better valuation at 19. 0x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HLN or CL or PG or CHD?

On trailing P/E, Haleon plc (HLN) is the cheapest at 19.

0x versus Colgate-Palmolive Company at 33. 2x. On forward P/E, The Procter & Gamble Company is actually cheaper at 21. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Haleon plc wins at 2. 63x versus The Procter & Gamble Company's 3. 78x.

03

Which is the better long-term investment — HLN or CL or PG or CHD?

Over the past 5 years, Haleon plc (HLN) delivered a total return of +31.

7%, compared to +13. 7% for Church & Dwight Co. , Inc. (CHD). Over 10 years, the gap is even starker: PG returned +119. 3% versus HLN's +31. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HLN or CL or PG or CHD?

By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at -0.

00β versus Church & Dwight Co. , Inc. 's 0. 14β — meaning CHD is approximately -3261% more volatile than CL relative to the S&P 500. On balance sheet safety, Haleon plc (HLN) carries a lower debt/equity ratio of 52% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — HLN or CL or PG or CHD?

By revenue growth (latest reported year), Church & Dwight Co.

, Inc. (CHD) is pulling ahead at 1. 6% versus -4. 0% for Haleon plc (HLN). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to -25. 1% for Colgate-Palmolive Company. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HLN or CL or PG or CHD?

The Procter & Gamble Company (PG) is the more profitable company, earning 19.

0% net margin versus 10. 5% for Colgate-Palmolive Company — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 17. 4% for CHD. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HLN or CL or PG or CHD more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Haleon plc (HLN) is the more undervalued stock at a PEG of 2. 63x versus The Procter & Gamble Company's 3. 78x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, The Procter & Gamble Company (PG) trades at 21. 1x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 3. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 10. 8% to $161. 88.

08

Which pays a better dividend — HLN or CL or PG or CHD?

All stocks in this comparison pay dividends.

The Procter & Gamble Company (PG) offers the highest yield at 2. 8%, versus 1. 3% for Church & Dwight Co. , Inc. (CHD).

09

Is HLN or CL or PG or CHD better for a retirement portfolio?

For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

00), 2. 6% yield). Both have compounded well over 10 years (CL: +47. 0%, CHD: +113. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HLN and CL and PG and CHD?

These companies operate in different sectors (HLN (Healthcare) and CL (Consumer Defensive) and PG (Consumer Defensive) and CHD (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

HLN

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.7%
Run This Screen
Stocks Like

CL

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Stocks Like

PG

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

CHD

Stable Dividend Mega-Cap

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HLN and CL and PG and CHD on the metrics below

Revenue Growth>
%
(HLN: -0.4% · CL: 5.8%)
Net Margin>
%
(HLN: 14.5% · CL: 10.5%)
P/E Ratio<
x
(HLN: 19.0x · CL: 33.2x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.